Vanguard Health Syst (VHS) Issues FY13 Earnings Guidance
Vanguard Health Syst (VHS) issued an update on its FY13 earnings guidance on Tuesday morning. The company provided EPS guidance of $0.74-0.93 for the period.
Shares of Vanguard Health Syst (VHS) traded down 3.24% during mid-day trading on Tuesday, hitting $10.45. Vanguard Health Syst (VHS) has a 52 week low of $6.92 and a 52 week high of $12.79. The company has a market cap of $804.8 million and a P/E ratio of 15.13.
Vanguard Health Syst last announced its earnings results on Tuesday, October 30th. The company reported $0.17 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.15 by $0.02. The company had revenue of $1.44 billion for the quarter, compared to the consensus estimate of $1.52 billion. The company’s quarterly revenue was up 2.4% on a year-over-year basis. On average, analysts predict that Vanguard Health Syst (VHS) will post $0.83 earnings per share for the current fiscal year.
Several analysts have also recently commented on the stock. Analysts at Barclays Capital initiated coverage on shares of Vanguard Health Syst in a research note to investors on Thursday, October 11th. They set an overweight rating and a $15.00 price target on the stock. On a related note, analysts at Avondale Partners initiated coverage on shares of Vanguard Health Syst in a research note to investors on Tuesday, September 25th. They set an outperform rating on the stock. Finally, analysts at Imperial Capital initiated coverage on shares of Vanguard Health Syst in a research note to investors on Thursday, September 6th. They set an outperform rating and a $12.00 price target on the stock.
Vanguard Health Systems, Inc. (Vanguard) owns and operates acute care hospitals, complementary outpatient facilities and related health plans principally located in urban and suburban markets.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.